45/100BNike stock forecast 2027–2031What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Nike is 37.15, 3.7% below the current price of 38.59. Their targets range from 19.00 to 60.00.
Of the 27 firms that rated Nike in the past 12 months, 7 rate it buy or strong buy, 15 hold and 5 sell or strong sell (each firm at its latest rating): a Hold consensus.
Analysts' 1-year price targets range from 19.00 to 60.00, with an average of 37.15.
| Buy | 7 | |
| Hold | 15 | |
| Sell | 5 |
12-month price target
| Highest target | 60.00 |
| Average target | 37.15 |
| Lowest target | 19.00 |
| Current price | 38.59 |
Nike price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Nike price target and rating?
How analysts rate Nike, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
7 of 27 firms rate it buy now, against 20 of 26 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Nike analyst upgrades, downgrades and price targets
The latest rating change came on 5 November 2026, when Truist Securities downgraded Nike from Hold to Sell. The most recent new target came from Barclays on 22 October 2026: 45.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 5 Nov 2026 | Truist Securities | Downgraded · Hold → Sell | — | — | — |
| 22 Oct 2026 | Barclays | Reiterated · Overweight | 37.00 → 45.00 | +21.6% | 37.53 |
| 9 Oct 2026 | Deutsche Bank Krisztina Katai | — | 37.00 → 33.00 | -10.8% | 35.02 |
| 6 Oct 2026 | Berenberg Bank | — | 49.00 → 27.50 | -43.9% | 33.96 |
| 5 Oct 2026 | Barclays | Reiterated · Overweight | 48.00 → 37.00 | -22.9% | 33.87 |
| 2 Oct 2026 | UBS Jay Sole | Reiterated · Neutral | 42.00 → 34.00 | -19.0% | 33.10 |
| 2 Oct 2026 | Evercore ISI Michael Binetti | Reiterated · In Line | 46.00 → 28.00 | -39.1% | 33.22 |
| 2 Oct 2026 | Morgan Stanley Alex Straton | Reiterated · Underweight | 31.00 → 27.00 | -12.9% | 33.21 |
| 2 Oct 2026 | Bernstein Nick Anderson | — | 68.00 → 45.00 | -33.8% | 35.15 |
| 2 Oct 2026 | Robert W. Baird Jonathan Komp | — | 44.00 → 36.00 | -18.2% | 35.15 |
| 2 Oct 2026 | Piper Sandler | Reiterated · Neutral | 38.00 → 28.00 | -26.3% | 35.15 |
| 2 Oct 2026 | Guggenheim Simon Siegel | Reiterated · Buy | 60.00 → 50.00 | -16.7% | 35.15 |
| 2 Oct 2026 | BNP Paribas | Reiterated · Underperform | 35.00 → 19.00 | -45.7% | 35.15 |
| 2 Oct 2026 | Wells Fargo Ike Boruchow | Reiterated · Equal Weight | 40.00 → 30.00 | -25.0% | 35.15 |
| 2 Oct 2026 | Telsey Advisory Christina Fernandez | Reiterated · Market Perform | 44.00 → 35.00 | -20.5% | 35.15 |
| 2 Oct 2026 | BMO Capital Simeon Siegel | — | 30.00 → 25.00 | -16.7% | 35.15 |
| 2 Oct 2026 | Truist Financial Joseph Civello | Reiterated · Hold | 24.00 → 29.00 | +20.8% | 35.15 |
| 2 Oct 2026 | Goldman Sachs Brooke Roach | Reiterated · Neutral | 46.00 → 30.00 | -34.8% | 35.15 |
| 2 Oct 2026 | BTIG Robert Drbul | Reiterated · Buy | 55.00 → 50.00 | -9.1% | 35.15 |
| 2 Oct 2026 | Truist Financial | — | 42.00 → 24.00 | -42.9% | 35.15 |
| 2 Oct 2026 | Stifel Nicolaus Peter McGoldrick | Reiterated · Hold | 40.00 → 36.00 | -10.0% | 35.15 |
| 2 Oct 2026 | Jefferies Randal Konik | — | 75.00 → 60.00 | -20.0% | 35.15 |
| 2 Oct 2026 | Freedom Broker | Upgraded · Sell → Buy | — | — | — |
| 29 Sept 2026 | RBC Capital | Reiterated · Sector Perform | 45.00 → 40.00 | -11.1% | 36.39 |
| 28 Sept 2026 | HSBC | — | 40.00 | — | 36.10 |
| 28 Sept 2026 | Deutsche Bank | Reiterated · Hold | 43.00 → 37.00 | -14.0% | 36.13 |
| 28 Sept 2026 | Piper Sandler Anna Andreeva | Reiterated · Neutral | 45.00 → 38.00 | -15.6% | 35.75 |
| 25 Sept 2026 | B of A Securities | Downgraded · Neutral → Underperform | — | — | — |
| 23 Sept 2026 | Oppenheimer | Reiterated · Outperform | 60.00 → 52.00 | -13.3% | 35.90 |
| 23 Sept 2026 | Barclays Adrienne Yih | Reiterated · Overweight | 52.00 → 48.00 | -7.7% | 36.10 |
| 21 Sept 2026 | Stifel Nicolaus Peter McGoldrick | Reiterated · Hold | 45.00 → 40.00 | -11.1% | 35.51 |
| 17 Sept 2026 | UBS | Reiterated · Neutral | 48.00 → 42.00 | -12.5% | 35.78 |
| 15 Sept 2026 | Telsey Advisory Christina Fernandez | Reiterated · Market Perform | 47.00 → 44.00 | -6.4% | 37.05 |
| 14 Sept 2026 | Robert W. Baird | — | 44.00 | — | 36.80 |
| 14 Sept 2026 | Baird | Downgraded · Outperform → Neutral | — | — | — |
| 10 Sept 2026 | Morgan Stanley Alex Straton | — | 72.00 → 31.00 | -56.9% | 37.35 |
| 8 Sept 2026 | BMO Capital Kelly Crago | — | 30.00 | — | 38.10 |
| 26 Aug 2026 | Truist Financial Joseph Civello | Downgraded · Buy → Hold | 69.00 → 42.00 | -39.1% | 39.48 |
| 25 Aug 2026 | RBC Capital Piral Dadhania | Reiterated · Sector Perform | 50.00 → 45.00 | -10.0% | 40.75 |
| 4 Aug 2026 | JP Morgan | Downgraded · Neutral → Underweight | — | — | — |
| 29 Jul 2026 | Bernstein Nick Anderson | — | 72.00 → 68.00 | -5.6% | 43.05 |
| 3 Jul 2026 | Berenberg Bank Nick Anderson | — | 49.00 | — | 44.09 |
| 1 Jul 2026 | UBS Jay Sole | Reiterated · Neutral | 50.00 → 48.00 | -4.0% | 42.86 |
| 1 Jul 2026 | Jefferies | Reiterated · Buy | 110.00 → 75.00 | -31.8% | 42.55 |
| 1 Jul 2026 | Stifel Nicolaus | Reiterated · Hold | 50.00 → 45.00 | -10.0% | 41.05 |
| 1 Jul 2026 | Wells Fargo | Reiterated · Equal Weight | 45.00 → 40.00 | -11.1% | 41.05 |
| 1 Jul 2026 | Barclays | Reiterated · Overweight | 64.00 → 52.00 | -18.8% | 41.05 |
| 1 Jul 2026 | Piper Sandler | Reiterated · Neutral | 50.00 → 45.00 | -10.0% | 41.05 |
| 1 Jul 2026 | Telsey Advisory Christina Fernandez | Reiterated · Market Perform | 72.00 → 47.00 | -34.7% | 41.05 |
| 1 Jul 2026 | Bernstein | Reiterated · Outperform | 85.00 → 72.00 | -15.3% | 41.05 |
Nike EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Analysts expect Nike's EPS to fall 4.7% a year until 2029. Over the last 5 years it fell 10.0% a year, and over the last 3 years it fell 13.4%.
Analysts expect Nike's revenue to fall 1.7% a year until 2029. Over the last 5 years it grew 0.8% a year, and over the last 3 years it fell 3.2%.
Revenue
EPS
Does Nike beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 77.0% off the result, either way, and their revenue estimate 2.6%, over the last 12 quarters.
- EPS beats
- 99 / 125
- Revenue beats
- 90 / 112
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +77.0%
- Since
- March 1993
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q1 FY2027 | 1 Oct 2026 | 0.43 | 0.48 | +10.8% | 11.32B | 11.21B | -0.9% |
| Q4 FY2026 | 30 Jun 2026 | 0.11 | 0.72 | +554.5% | 10.85B | 10.97B | +1.1% |
| Q3 FY2026 | 31 Mar 2026 | 0.29 | 0.35 | +20.4% | 11.23B | 11.28B | +0.4% |
| Q2 FY2026 | 18 Dec 2025 | 0.37 | 0.53 | +41.4% | 12.21B | 12.43B | +1.8% |
| Q1 FY2026 | 30 Sept 2025 | 0.27 | 0.49 | +80.1% | 10.99B | 11.72B | +6.6% |
| Q4 FY2025 | 26 Jun 2025 | 0.13 | 0.14 | +7.4% | 10.73B | 11.10B | +3.4% |
| Q3 FY2025 | 20 Mar 2025 | 0.30 | 0.54 | +79.6% | 11.02B | 11.27B | +2.3% |
| Q2 FY2025 | 19 Dec 2024 | 0.65 | 0.78 | +20.0% | 12.13B | 12.35B | +1.8% |
| Q1 FY2025 | 1 Oct 2024 | 0.52 | 0.70 | +34.6% | 11.64B | 11.59B | -0.5% |
| Q4 FY2024 | 27 Jun 2024 | 0.83 | 1.01 | +21.7% | 12.86B | 12.61B | -2.0% |
| Q3 FY2024 | 21 Mar 2024 | 0.74 | 0.98 | +32.4% | 12.28B | 12.43B | +1.2% |
| Q2 FY2024 | 21 Dec 2023 | 0.85 | 1.03 | +21.2% | 12.32B | 13.39B | +8.6% |
Nike stock price 2027–2031: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If Nike's earnings keep growing at the -4.6% a year analysts expect to FY2029, it would earn about 1.66 a share in FY2031. At the P/E it has traded at over the last five years (18.5 to 32.2) that is 30.56 to 53.28 a share, or 43.24 at its average P/E of 26.1. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2027 | 1.27 | 23.42 | 33.15 | 40.84 |
| FY2028 | 1.50 | 27.71 | 39.22 | 48.32 |
| FY2029 | 1.82 | 33.55 | 47.47 | 58.49 |
| FY2030 (extrapolated) | 1.73 | 32.02 | 45.31 | 55.82 |
| FY2031 (extrapolated) | 1.66 | 30.56 | 43.24 | 53.28 |
Each year's EPS is the analysts' consensus to FY2029; the years after grow -4.6% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (18.5, 26.1, 32.2).
Is Nike stock undervalued or overvalued?How does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
Nike's P/E of 18.5 is near the bottom of its 5-year range (16.2 to 45.3, median 30.8). Analysts do not expect slower growth than in recent years, so it is cheaper than its usual level. Fair value is not a reliable guide for Nike: its earnings swing (EPS fell 42.1% in FY2025), so its usual P/E would mislead. Its forward P/E, on the consensus for FY2027, is 30.4.
- Price to earnings ratio (TTM)What is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 18.46
- Five-year median P/EWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 30.85
- Five-year P/E range
- 16.2 – 45.3
- Forward P/E (FY2027)What is the forward P/E ratio? Forward P/E divides a share's price by the earnings per share analysts expect in the coming year, rather than last year's actual earnings.
- 30.41
- To the average targetWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
- -3.7%
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 99.090 | 194.93146Price 99.09244 | +96.7% | |
| 42.225 | 82.9546Price 42.23165 | +96.4% | |
| 186.680 | 360.82271Price 186.68451 | +93.3% | |
| 213.670 | 405.57304Price 213.67507 | +89.8% | |
| 161.160 | 305.51157Price 161.16396 | +89.6% | |
| 160.650 | 300.09225Price 160.65375 | +86.8% | |
| 165.860 | 308.95212Price 165.86442 | +86.3% |
Furthest below the fair value on each stock's page, updated every day.